These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 8778201

  • 1. Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings.
    Tagawa M, Yokosuka O, Imazeki F, Ohto M, Omata M.
    J Hepatol; 1996 Mar; 24(3):328-34. PubMed ID: 8778201
    [Abstract] [Full Text] [Related]

  • 2. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A, Locarnini S, Chou ST, Smallwood R, Angus P.
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [Abstract] [Full Text] [Related]

  • 3. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
    Jilbert AR, Botten JA, Miller DS, Bertram EM, Hall PM, Kotlarski J, Burrell CJ.
    Virology; 1998 May 10; 244(2):273-82. PubMed ID: 9601498
    [Abstract] [Full Text] [Related]

  • 4. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN, Slomka MJ, Maung M.
    J Med Virol; 1994 Mar 10; 42(3):306-10. PubMed ID: 8006644
    [Abstract] [Full Text] [Related]

  • 5. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF, Miller DS, Foster WK, Burrell CJ, Jilbert AR.
    J Virol; 2005 Oct 10; 79(19):12242-52. PubMed ID: 16160150
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY, Cheng AC, Wang MS, Xu DW, Zeng W, Li Z.
    Acta Pharmacol Sin; 2007 Oct 10; 28(10):1652-8. PubMed ID: 17883953
    [Abstract] [Full Text] [Related]

  • 8. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T, Yokosuka O, Tagawa M, Saisho H, Tamura S, Fukuda I, Omata M.
    J Hepatol; 2000 May 10; 32(5):850-8. PubMed ID: 10845674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver.
    Wei PH, Wu SZ, Mu XM, Xu B, Su QJ, Wei JL, Yang Y, Qin B, Xie ZC.
    J Ethnopharmacol; 2015 Feb 03; 160():1-5. PubMed ID: 25446633
    [Abstract] [Full Text] [Related]

  • 14. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
    Barraud L, Guerret S, Chevallier M, Borel C, Jamard C, Trepo C, Wild CP, Cova L.
    Hepatology; 1999 Apr 03; 29(4):1317-23. PubMed ID: 10094981
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.
    Turin F, Borel C, Benchaib M, Kay A, Jamard C, Guguen-Guillouzo C, Trépo C, Hantz O.
    J Virol; 1996 May 03; 70(5):2691-6. PubMed ID: 8627742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.